Insider · CIK 0001620146

NIFFENEGGER KATHI

Reports to the SEC for 1 company · PORT HUENEME, CA

sec.gov

Transactions

Companies

Filings

CIK

0001620146

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-11-02	EDSAEdesa Biotech, Inc.A Award	Chief Financial Officer	AAward	+8,888 sh	$1.13	+$9,999	10,715
2022-11-02	EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award	Chief Financial Officer	AAward	+4,444 sh	—	—	4,444
2022-11-02	EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award	Chief Financial Officer	AAward	+4,444 sh	—	—	4,444
2022-02-28	EDSAEdesa Biotech, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+43.5K sh	—	—	43,500
2021-04-22	EDSAEdesa Biotech, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2020-11-06	EDSAEdesa Biotech, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+609 sh	$4.00	+$2,436	1,827
2020-11-06	EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−609 sh	—	—	0
2020-10-13	EDSAEdesa Biotech, Inc. · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2020-02-12	EDSAEdesa Biotech, Inc. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+88.7K sh	—	—	88,699
2020-01-08	EDSAEdesa Biotech, Inc.A Award	Chief Financial Officer	AAward	+1,218 sh	$4.11	+$5,005.98	1,218
2020-01-08	EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award	Chief Financial Officer	AAward	+914 sh	—	—	914
2020-01-08	EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award	Chief Financial Officer	AAward	+609 sh	—	—	609
2018-03-12	EDSAEdesa Biotech, Inc. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2016-12-20	EDSAEdesa Biotech, Inc. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2015-12-22	EDSAEdesa Biotech, Inc. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2014-11-12	EDSAEdesa Biotech, Inc. · Stock Option (Right To Buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000

Recent filings

Accepted (ET)
Nov 44
NIFFENEGGER KATHI0001654954-22-014746
SEC(opens sec.gov)
Mar 74
NIFFENEGGER KATHI0001654954-22-002652
SEC(opens sec.gov)
Apr 264
NIFFENEGGER KATHI0001654954-21-004635
SEC(opens sec.gov)
Nov 94
NIFFENEGGER KATHI0001654954-20-011986
SEC(opens sec.gov)
Oct 144
NIFFENEGGER KATHI0001654954-20-011140
SEC(opens sec.gov)
Feb 144
NIFFENEGGER KATHI0001654954-20-001650
SEC(opens sec.gov)
Jan 104
NIFFENEGGER KATHI0001654954-20-000310
SEC(opens sec.gov)
Mar 144
NIFFENEGGER KATHI0001144204-18-014750
SEC(opens sec.gov)
Dec 214
Stellar Biotechnologies, Inc.0001144204-16-140709
SEC(opens sec.gov)
Dec 234
Stellar Biotechnologies, Inc.0001144204-15-072638
SEC(opens sec.gov)
Nov 134
Stellar Biotechnologies, Inc.0001102624-14-001897
SEC(opens sec.gov)

Companies

Edesa Biotech, Inc.Chief Financial OfficerEDSA

Address

C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET

PORT HUENEME, CA, 93041